MktsMarkets

Autolus Therapeutics plc
NASDAQ: AUTLKey statistics
AUTL News
Stories mentioning AUTL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 26,218 | 24,289 | 21,194 | 20,923 | 8,982 | 29.00 | 0.00 | 0.00 |
| Cost of Goods Sold | 24,568 | 25,330 | 28,643 | 24,445 | 17,951 | 11,387 | 0.00 | 0.00 |
| Gross Profit | 1,650 | (1,041) | (7,449) | (3,522) | (8,969) | (11,358) | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 21,210 | 35,633 | 27,892 | 27,430 | 26,734 | 30,830 | 40,323 | 36,612 |
| Sales General & Admin | 39,953 | 35,792 | 36,280 | 30,265 | 29,537 | 34,313 | 27,330 | 21,903 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (59,513) | (72,466) | (71,621) | (61,217) | (65,240) | (75,864) | (67,876) | (58,929) |
| Interest Income | 2,469 | 3,227 | 4,382 | 5,234 | 6,137 | 7,446 | 8,320 | 9,656 |
| Interest Expense | 11,124 | 22,836 | 10,520 | (6,829) | 10,143 | (30,835) | 10,686 | 10,174 |
| Other Expense | 100.00 | 167.00 | 84.00 | 135.00 | 129.00 | 410.00 | 54.00 | 56.00 |
| Pretax Income | (70,735) | (91,514) | (78,586) | (47,520) | (67,936) | (26,143) | (82,072) | (58,221) |
| Tax Provision | 863.00 | (1,182) | 532.00 | 397.00 | 2,225 | 1,463 | 22.00 | 51.00 |
| Net Income (Loss) | (71,598) | (90,332) | (79,118) | (47,917) | (70,161) | (27,606) | (82,094) | (58,272) |
| Earnings Per Share (Basic) | (0.27) | (0.34) | (0.30) | (0.18) | (0.26) | (0.11) | (0.31) | (0.22) |
| Earnings Per Share (Diluted) | (0.27) | (0.34) | (0.30) | (0.18) | (0.26) | (0.11) | (0.31) | (0.22) |
| Weighted Average Shares Outstanding (Basic) | 266,143 | 266,138 | 266,141 | 266,141 | 266,127 | 255,161 | 266,085 | 266,026 |
| Weighted Average Shares Outstanding (Diluted) | 266,143 | 266,138 | 266,141 | 266,141 | 266,127 | 255,161 | 266,085 | 266,026 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About AUTL
Autolus Therapeutics plc (NASDAQ: AUTL) is a stock listed on the Nasdaq Stock Market under the ticker symbol AUTL. It last traded at $1.28 (Nov 6, 2026, 4:00 PM ET), up 1.6% on the day. That gives Autolus Therapeutics a market capitalisation of $367.3M.
Over the past 52 weeks AUTL has traded between $1.18 and $2.58.
Revenue for the quarter ended Mar 31, 2026 was $26.2M; a net loss of $71.6M. Revenue was up 192% from $9.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $26.2M | -$71.6M | -273.1% |
| Dec 31, 2025 | $24.3M | -$90.3M | -371.9% |
| Sep 30, 2025 | $21.2M | -$79.1M | -373.3% |
| Jun 30, 2025 | $20.9M | -$47.9M | -229.0% |
From Autolus Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…